Streetbeat News

Analyst Ratings

PSTX

HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Poseida Therapeutics (NASDAQ:PSTX) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:10 am

AEO

Barclays analyst Adrienne Yih maintains an Overweight rating on American Eagle Outfitters (AEO) and raises the price target from $27 to $30.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:10 am

VSCO

Barclays analyst Adrienne Yih maintains an Equal-Weight rating on Victoria's Secret (VSCO) and lowers the price target from $25 to $15.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:08 am

JAMF

Needham analyst Joshua Reilly reiterated a Buy rating on Jamf Holding (NASDAQ:JAMF) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:06 am

MGNX

Barclays analyst Peter Lawson maintains an Overweight rating on Macrogenics (NASDAQ:MGNX) and raises the price target from $23 to $25.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:06 am

BLBD

Needham analyst Chris Pierce reiterated a Buy rating on Blue Bird (NASDAQ:BLBD) and maintained a $44 price target.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:05 am

ARHS

Barclays analyst Seth Sigman has maintained an Overweight rating on Arhaus (NASDAQ:ARHS) and increased the price target from $14 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:04 am

AKA

Telsey Advisory Group analyst Dana Telsey maintains a Market Perform rating on a.k.a. Brands Holding (NYSE:AKA) and raises the price target from $8 to $11.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:02 am

AVGO

Mizuho analyst Vijay Rakesh maintains a Buy rating on Broadcom (NASDAQ:AVGO) and raises the price target from $1550 to $1625, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:02 am

ARHS

Telsey Advisory Group analyst Joseph Feldman maintains an Outperform rating on Arhaus (NASDAQ:ARHS) and raises the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:00 am